Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G/A filed Aug 14, 2026

Name: Aspire Biopharma Holdings, Inc. SCHEDULE 13G/A (0000919574-26-005317)
Creator: Aspire Biopharma Holdings, Inc.
Published: 2026-08-14

Form type: SCHEDULE 13G/A
Filing date: Aug 14, 2026
Accession number: 0000919574-26-005317
Filer: Aspire Biopharma Holdings, Inc. (CIK 1847345)